Global Protein Therapeutics Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Type;

Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone and Others.

By Application;

Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others.

By End Use;

Hospitals And Clinics, Specialty Centers and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn265955624 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Protein Therapeutics Market (USD Million), 2021 - 2031

In the year 2024, the Global Protein Therapeutics Market was valued at USD 349.28 million. The size of this market is expected to increase to USD 590.92 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.8%.

The global protein therapeutics market is witnessing significant growth driven by the increasing prevalence of chronic diseases, advancements in biotechnology, and the expanding applications of protein-based drugs in various therapeutic areas. Protein therapeutics, which include monoclonal antibodies, cytokines, growth factors, and therapeutic enzymes, offer targeted treatment options with high specificity and efficacy. These biologic drugs are revolutionizing the treatment landscape by providing novel solutions for diseases such as cancer, autoimmune disorders, infectious diseases, and rare genetic conditions.

One of the key drivers of the protein therapeutics market is the growing demand for personalized medicine and precision therapies. Protein-based drugs can be engineered to target specific molecular pathways involved in disease pathogenesis, offering tailored treatment options for individual patients. Additionally, the development of innovative protein engineering techniques, such as antibody-drug conjugates and bispecific antibodies, further enhances the therapeutic potential of protein-based drugs, driving market expansion.

Moreover, the increasing investment in research and development by pharmaceutical companies and biotechnology firms is fueling the growth of the protein therapeutics market. With advancements in recombinant DNA technology, protein expression systems, and protein purification techniques, the production of biologic drugs has become more efficient and cost-effective. Furthermore, the approval of biosimilar versions of blockbuster protein therapeutics is expanding patient access to these life-saving medications, driving market competitiveness and fostering innovation in the biopharmaceutical industry. Overall, the global protein therapeutics market is poised for continued growth as biologic drugs continue to revolutionize the treatment of various diseases and improve patient outcomes.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Application
    3. Market Snapshot, By End Use
    4. Market Snapshot, By Region
  4. Global Protein Therapeutics Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Prevalence of Chronic Diseases
        2. Advancements in Biotechnology
        3. Expanding Applications in Various Therapeutic Areas
      2. Restraints
        1. High Development Costs
        2. Complex Regulatory Approval Processes
        3. Potential Immunogenicity and Safety Concerns

      3. Opportunities
        1. High Development Costs
        2. Complex Regulatory Approval Processes
        3. Potential Immunogenicity and Safety Concerns
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Protein Therapeutics Market, By Type, 2021 - 2031 (USD Million)
      1. Monoclonal Antibodies
      2. Insulin, Fusion Protein
      3. Erythropoietin, Interferon
      4. Human Growth Hormone
      5. Follicle Stimulating Hormone
      6. Others
    2. Global Protein Therapeutics Market, By Application, 2021 - 2031 (USD Million)
      1. Metabolic Disorders
      2. Immunologic Disorders
      3. Hematological Disorders
      4. Cancer
      5. Hormonal Disorders
      6. Genetic Disorders
      7. Others
    3. Global Protein Therapeutics Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals And Clinics
      2. Specialty Centers
      3. Others
    4. Global Protein Therapeutics Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Roche Holding AG
      2. Amgen Inc.
      3. Novo Nordisk A/S
      4. Johnson & Johnson
      5. AbbVie Inc.
      6. Pfizer Inc.
      7. Sanofi S.A.
      8. Merck & Co., Inc.
      9. Biogen Inc.
      10. Eli Lilly and Company
  7. Analyst Views
  8. Future Outlook of the Market